“ADVANCES IN TARGETED THERAPIES FOR THE TREATMENT OF LIGHT CHAIN AMYLOIDOSIS”, ISJM, vol. 5, no. 2, p. e10022, Apr. 2026, doi: 10.56238/isevmjv5n2-040.